[1] |
Long Q, Guo L, Jiang W, et al. Ending tuberculosis in China: health system challenges. Lancet Public Health, 2021, 6(12): e948-e953. doi:10.1016/S2468-2667(21)00203-6.
doi: 10.1016/S2468-2667(21)00203-6
pmid: 34838198
|
[2] |
Ding C, Wang S, Shangguan Y, et al. Epidemic Trends of Tuberculosis in China from 1990 to 2017: Evidence from the Global Burden of Disease Study. Infect Drug Resist, 2020, 13: 1663-1672. doi:10.2147/IDR.S249698.
doi: 10.2147/IDR.S249698
pmid: 32606817
|
[3] |
Zhang T, Zhang J, Wei L, et al. The global, regional, and national burden of tuberculosis in 204 countries and territories, 1990—2019. J Infect Public Health, 2023, 16(3): 368-375. doi:10.1016/j.jiph.2023.01.014.
doi: 10.1016/j.jiph.2023.01.014
URL
|
[4] |
Dong Z, Yao HY, Yu SC, et al. Changes in Notified Incidence of Pulmonary Tuberculosis in China, 2005—2020. Biomed Environ Sci, 2023, 36(2):117-126. doi:10.3967/bes2023.015.
doi: 10.3967/bes2023.015
pmid: 36861190
|
[5] |
刘志辉, 钟球. 全面应对耐多药结核病的挑战——问题、困惑、行动和希望. 实用医学杂志, 2022, 38(13):1573-1577. doi:10.3969/j.issn.1006-5725.2022.13.001.
doi: 10.3969/j.issn.1006-5725.2022.13.001
|
[6] |
World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization, 2022.
|
[7] |
中华人民共和国国家疾病预防控制局综合司, 中华人民共和国国家卫生健康委员会办公厅. 关于进一步加强耐药结核病防治工作的通知. 国疾控传防发〔2023〕4号. 2023-02-17.
|
[8] |
中国疾病预防控制中心结核病预防控制中心. 中国结核病防治工作技术指南. 北京: 人民卫生出版社, 2021.
|
[9] |
中国防痨协会. 耐药结核病化学治疗指南(2009). 中华结核和呼吸杂志, 2010, 33(7):485-497. doi:10.3760/cma.j.issn.1001-0939.2010.07.004.
doi: 10.3760/cma.j.issn.1001-0939.2010.07.004
|
[10] |
World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020.
|
[11] |
World Health Organization. Compendium of WHO guidelines and associated standards. Geneva: World Health Organization, 2018.
|
[12] |
中国疾病预防控制中心. 结核病合作项目介绍[EB/OL]. [2022-12-10]. https://tb.chinacdc.cn/hzx/xmjsh/201208/t20120814_66833.htm.
|
[13] |
江苏省人民政府办公厅. 省政府办公厅关于印发江苏省“十二五”结核病防治规划和江苏省消除麻风病危害规划(2012—2020年)的通知. 苏政办发〔2012〕97号. 2012-05-18.
|
[14] |
王坚杰, 周美兰, 任欣, 等. 2007―2020年武汉市耐药肺结核高危人群耐药流行趋势. 中华疾病控制杂志, 2022, 26(11): 1353-1359. doi:10.16462/j.cnki.zhjbkz.2022.11.020.
doi: 10.16462/j.cnki.zhjbkz.2022.11.020
|
[15] |
车晓玲, 吴清芳, 吕德良, 等. 深圳市全球基金耐多药结核病防治项目实施效果分析. 中国热带医学, 2017, 17(10): 988-990. doi:10.13604/j.cnki.46-1064/r.2017.10.08.
doi: 10.13604/j.cnki.46-1064/r.2017.10.08
|
[16] |
王坚杰, 周美兰, 杜义祥, 等. 武汉市耐药/耐多药结核病影响因素分析. 中华疾病控制杂志, 2017, 21(2):164-167. doi:10.16462/j.cnki.zhjbkz.2017.02.014.
doi: 10.16462/j.cnki.zhjbkz.2017.02.014
|
[17] |
GBD 2019 Tuberculosis Collaborators. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990—2019: results from the Global Burden of Disease Study 2019. Lancet Infect Dis, 2022, 22(2): 222-241. doi:10.1016/S1473-3099(21)00449-7.
doi: 10.1016/S1473-3099(21)00449-7
URL
|
[18] |
沈鸿程, 杜雨华, 张丹妮, 等. 2014—2019年广州市耐药肺结核高危人群耐药情况及影响因素分析. 中国防痨杂志, 2022, 44(12): 1279-1287. doi:10.19982/j.issn.1000-6621.20220284.
doi: 10.19982/j.issn.1000-6621.20220284
|
[19] |
World Health Organization. Programmatic Management of Drug Resistant Tuberculosis. Geneva: World Health Organization. 2017.
|
[20] |
Tiberi S, Utjesanovic N, Galvin J, et al. Drug resistant TB-latest developments in epidemiology, diagnostics and management. Int J Infect Dis, 2022, 124 Suppl 1: S20-S25. doi:10.1016/j.ijid.2022.03.026.
doi: 10.1016/j.ijid.2022.03.026
|
[21] |
Liu X, Thompson J, Dong H, et al. Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial. Lancet Glob Health, 2023, 11(5): e693-e703. doi:10.1016/S2214-109X(23)00068-2.
doi: 10.1016/S2214-109X(23)00068-2
pmid: 37061308
|
[22] |
Shi W, Davies Forsman L, Hu Y, et al. Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China. Int J Infect Dis, 2020, 96: 390-397. doi:10.1016/j.ijid.2020.04.049.
doi: S1201-9712(20)30265-4
pmid: 32353546
|
[23] |
李玲. 安徽省肺结核流行特征与患者直接经济负担调查研究. 合肥: 安徽医科大学, 2020.
|
[24] |
郑岚. 湖南省结核病医院耐多药肺结核患者治疗依从性及其影响因素研究. 长沙: 中南大学, 2013. doi:10.7666/d.Y2426194.
doi: 10.7666/d.Y2426194
|
[25] |
丰达星, 张璐, 吕宛玉, 等. 我国耐多药结核患者治疗依从性影响因素meta分析. 实用预防医学, 2019, 26(7): 823-826. doi:10.3969/j.issn.1006-3110.2019.07.014.
doi: 10.3969/j.issn.1006-3110.2019.07.014
|